In univariable Cox regression analysis neither baseline characteristics such as the BRAF status or the tumor load at treatment start (LDH/S100) nor the pretreatments and therapy regimes used were significantly influencing PFS with metabolic response as the only significant factor. Here, BRAF is linked to neoplasm.